Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07398391 · ClinicalTrials.gov registry record · NA

Blood Pressure Care for Advancing Real-World Evidence (BPCARE)

A NA study of Hypertension and High Blood Pressure, sponsored by University of California, San Diego.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
2
Study locations

NCT07398391: Recruiting NA study of Hypertension and High Blood Pressure, sponsored by University of California, San Diego.

NCT07398391 is a NA study of Hypertension and High Blood Pressure that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 250 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07398391, a NA study of Hypertension and High Blood Pressure, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
2
Study locations

Study Summary

The goal of this randomized clinical trial is to determine whether a community health worker-delivered, multi-component behavioral intervention can improve antihypertensive medication adherence and blood pressure control among adult refugees with hypertension who are prescribed antihypertensive medications. The main questions it aims to answer are: 1. Does participation in the BPCARE intervention improve antihypertensive medication adherence compared to enhanced usual care? 2. Does participation in the BPCARE intervention improve blood pressure control and persistence over time compared to enhanced usual care? Researchers will compare participants randomized to the BPCARE intervention to those receiving enhanced usual care (hypertension information and a home blood pressure monitor) to determine the effects on medication adherence, blood pressure control, and persistence. Participants will: * Be randomly assigned to either the BPCARE intervention or enhanced usual care * Receive hypertension education and a home blood pressure monitor * Participate in community health worker-delivered sessions that include hypertension and medication education, motivational interviewing, problem-solving, and action planning (intervention arm only) * Complete questionnaires assessing medication adherence and related psychosocial factors * Have blood pressure monitored using connected home blood pressure devices * Complete pill counts to assess medication adherence over a nine-month follow-up period

Primary Outcome

Test the efficacy of BPCARE in improving antihypertensive medication adherence at 6 months post randomization (primary outcome; via self-report (Hill-Bone Compliance questionnaire), and unannounced pill counts (using video telecommunications)) compared to enhanced usual care. Hypotheses: BPCARE improves antihypertensive medication adherence H1a through H1b increased hypertension and medication adherence knowledge, H1c increased disease risk perceptions and therapeutic interest and motivation, H1

Interventions

  • BEHAVIORAL BPCARE Intervention

Study Locations (2)

California

  • University of California, San Diego - San Diego
  • Family Health Centers of San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2026-01-09
Est. Completion 2030-05
Phase NA
University of California, San Diego

775 total trials

What NCT07398391 shows while recruiting

NCT07398391 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (93% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which BPCARE Intervention is the first listed.

NCT07398391 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07398391 about?

NCT07398391 is a clinical study titled "Blood Pressure Care for Advancing Real-World Evidence (BPCARE)". The goal of this randomized clinical trial is to determine whether a community health worker-delivered, multi-component behavioral intervention can improve antihypertensive medication adherence and blood pressure control among adult refugees with hypertension who are prescribed antihypertensive medi...

What is the current status of trial NCT07398391?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2026-01-09. Estimated completion is 2030-05.

What conditions does trial NCT07398391 study?

This clinical trial studies the following conditions: Hypertension, High Blood Pressure.

What interventions are being tested in trial NCT07398391?

The interventions under investigation include: BPCARE Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07398391?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07398391 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07398391's enrollment target sits among peer trials

250 194th of 470 higher than 274 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07398391, the US trial registry maintained by the National Library of Medicine. NCT07398391 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.